Mice Model Market (Microinjection, Embryonic Stem Cell) Worth $1,819.9 Million by 2018 – New Report by MarketsandMarkets

(PRWEB) February 25, 2014

This report studies Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018. The market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.

Browse 116 market data tables and 85 figures spread through 339 pages and in-depth TOC on "Mice Model Market": http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html

Early buyers will receive 10% customization on this report.

The global market (models and services) is valued at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.

Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1308.

The global mice model market is categorized into four broad segments, namely, by type, by technology, by disease, and by service. The mice model market, by type, comprises of inbred, outbred, congenic/hybrid, surgically modified, knockout, and spontaneous mutant mice. The market for technology is segmented into microinjection, embryonic stem cell technique, virus/vector, nuclear transferase, genetically modified sperm, and others. By disease, the mice model market is segmented into diabetes, CNS, oncology, cardiovascular, immunology and inflammation, metabolism and regulation, and others. The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The report also includes the mice care products market, which includes cages, feed, bedding, and others.

The expanding global biotechnology and pharmaceutical industries and increasing government investments, funds, and grants have stimulated the usage of advanced mice models in the biotechnology and pharmaceutical industries. Furthermore, research activities in the fields of cancer, HIV, and diabetes have increased the application areas of mice models. Various factors such as technological advancements, incessant rise in new product launches, and increasing number of conferences are propelling the growth of the mice model market.

North America accounts for the largest share of the mice model market. This large share can be attributed to the growing biomedical research as well as the presence of major pharmaceutical companies that undertake preclinical activities. Asia is expected to witness a high growth in the mice model market in the forecast period. A number of factors such as growth in translational research in Singapore; regenerative medicines in Japan; the large number of ongoing and future biomedical research projects in China and Japan; and the growing number of R&D outsourcing activities in China, India, and Japan are propelling the demand for mice models in Asia.

The major players in the mice model market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

See more here:
Mice Model Market (Microinjection, Embryonic Stem Cell) Worth $1,819.9 Million by 2018 - New Report by MarketsandMarkets